Tethering of Epidermal Growth Factor Family Members to Dendrimer Crosslinked Collagen Gels
To enhance growth factor (GF) bioavailability, epidermal growth factor (EGF) and heparin-binding epidermal growth factor (HB-EGF) were tethered, via carbodiimide chemistry, to dendrimer crosslinked collagen (CG) gels, either during or following gel fabrication. GF tethering was achieved
either via step-wise modification, with gels soaked in activated GF solutions, or via bulk modification with various GF solutions added to the collagen suspension prior to full dendrimer crosslinking of CG gels. Conjugation of EGF and HB-EGF to CG gels was tunable in relation to the original
concentration of activated GF exposed to gels. Slightly higher amounts of tethered EGF, compared to HB-EGF, were initially obtained following step-wise conjugation, but differences were not evident following extensive rinsing, indicating the presence of both sorbed and tethered protein. Final
tethered GF amounts were found to be dependent on solution concentration. As with step-wise modification, bulk modification of CG gels resulted in GF retention that could be tailored by adjusting the amount of GF added to the collagen suspension during gel fabrication. However, the various
GF solutions utilized for CG bulk modification did not differ in terms of GF incorporation, following extensive rinsing, and represented between 2–5% of the originally added GF amount. Bioactivity of EGF and HB-EGF was enhanced following step-wise conjugation to gels, as was verified
with proliferation of human corneal epithelial cells (HCEC); however, bulk modification of CG gels, with tethered GF, only maintained HCEC proliferation, suggesting step-wise conjugation is a favourable method for HB-EGF and EGF tethering to CG gels.
Keywords: COLLAGEN; CORNEAL EPITHELIUM; DENDRIMERS; EPIDERMAL GROWTH FACTOR (EGF); HEPARIN-BINDING EPIDERMAL GROWTH FACTOR (HB-EGF); TISSUE ENGINEERED CORNEAL EQUIVALENTS (TECE)
Document Type: Research Article
Publication date: 01 November 2014
- Journal of Biomaterials and Tissue Engineering (JBT) is an international peer-reviewed journal that covers all aspects of biomaterials, tissue engineering and regenerative medicine. The journal focuses on the broad spectrum of research topics including all types of biomaterials, their properties, bioimplants and medical devices, biofilms, bioimaging, BioMEMS/NEMS, biosensors, fibers, tissue scaffolds, tissue engineering and modeling, artificial organs, tissue interfaces, interactions between biomaterials, blood, cells, tissues, and organs, regenerative medicine and clinical performance.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content